2010
DOI: 10.1016/j.mce.2010.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Pituitary tumors: Cell type-specific roles for BMP-4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(19 citation statements)
references
References 31 publications
0
17
0
2
Order By: Relevance
“…The effect of gonadal steroids has been reviewed recently (Handa and Weiser 2014). It is possible that variations in E 2 concentrations during the oestrous cycle, and particularly at PE (when maximum concentrations are reached), have an impact on the HPA axis, stimulating the synthesis and/or secretion of ACTH by means of different molecular pathways (Altemus et al 2001;Hall et al 2001;Labeur et al 2010). Moreover, the drop in E 2 concentrations after PE is accompanied by a drop in ACTH concentrations, suggesting that the stimulatory effect of E 2 on corticotroph cells begins to diminish.…”
Section: Discussionmentioning
confidence: 99%
“…The effect of gonadal steroids has been reviewed recently (Handa and Weiser 2014). It is possible that variations in E 2 concentrations during the oestrous cycle, and particularly at PE (when maximum concentrations are reached), have an impact on the HPA axis, stimulating the synthesis and/or secretion of ACTH by means of different molecular pathways (Altemus et al 2001;Hall et al 2001;Labeur et al 2010). Moreover, the drop in E 2 concentrations after PE is accompanied by a drop in ACTH concentrations, suggesting that the stimulatory effect of E 2 on corticotroph cells begins to diminish.…”
Section: Discussionmentioning
confidence: 99%
“…Jis pri si jun gia prie 1 ar 2 tipo se ri no / tre o ni no ki na zës re cep to riø, ku riø yra ir hi po fizë je [23,31]. Bu vo nu sta ty ta, kad, ser gant HA, su ma þë ja ðio bal ty mo re gu lia ci ja (ti riant jo mRNR), ta èiau me chaniz mas bu vo ne DNR me ti li ni mas, o his to nø mo di fi ka cijos -pa ste bë ti pa di dë jae his to no H3 li zi no 27 tri me ti li ni mo (H3K27Me3) ly giai [31].…”
Section: Sporadinës Haunclassified
“…Jis pri si jun gia prie 1 ar 2 tipo se ri no / tre o ni no ki na zës re cep to riø, ku riø yra ir hi po fizë je [23,31]. Bu vo nu sta ty ta, kad, ser gant HA, su ma þë ja ðio bal ty mo re gu lia ci ja (ti riant jo mRNR), ta èiau me chaniz mas bu vo ne DNR me ti li ni mas, o his to nø mo di fi ka cijos -pa ste bë ti pa di dë jae his to no H3 li zi no 27 tri me ti li ni mo (H3K27Me3) ly giai [31]. Pa ban dþius ið ma tuo ti BMP-4 kon cen tra ci jas ávai riais me to dais (ELI SA, Wes t ern Blot) ir ser gant spo ra di në mis HA, gau ti ávai rûs re zul ta tai, ku riais re mian tis ga li ma bu vo da ry ti ið va dà, kad ðis bal ty mas gal ir ska ti na pro lak ti no mø, bet slo pi na so ma tot ro pi no mø au gimà [23].…”
Section: Sporadinës Haunclassified
“…In gonadotropes, GnRH induces an antiproliferative response that is further modified by activin, suggesting that transforming growth factor (TGF)-β signaling cooperates with GnRH to provide the appropriate differentiated phenotype (Zhang et al, 2006). There is also increasing evidence that locally produced BMPs play a critical role in the pathogenesis of human pituitary tumors (Labeur et al, 2010). In this regard, we previously reported the characteristics of human FSH-producing adenomas compared with those of nonfunctioning adenomas and showed that the expression of follistatin, which neutralizes BMP/activin actions by binding, was decreased in human FSH-producing adenomas (Takeda et al, 2003).…”
Section: Introductionmentioning
confidence: 99%